The Loss of Expression of Transforming Growth Factor-β Receptors Correlates with the Histopathologic Tumor Grade in Bladder Transitional Cell Carcinoma Patients

Dong Hyeon Lee, Seung Choul Yang, Sung Joon Hong, Byung Ha Chung, Hyun Jik Chung, Hideo Tokunaga, Isaac Y. Kim, Yun S. Song, Seth P. Lerner, Ronald A. Morton

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Transforming growth factor-β (TGF-β), a pleiotropic growth factor, is a potent inhibitor of cellular proliferation in cells of epithelial origin. Recently, it has been suggested that a loss of sensitivity to TGF- β through a loss of expression of TGF-β receptors TβSR-I and TβR-II - is associated with tumor initiation and progression. Therefore, to investigate the relationship between TGF-β receptors expression and carcinogenesis of bladder TCC, this study examined the expression of TβR-I and TβR-II in 46 bladder TCC patients using immunohistochemistry. Since histopathological grade is a widely accepted marker of prognosis, the results were compared in relation to the three grades of bladder TCC. The results demonstrated that the loss of TGF-β receptors expression is associated with increasing histopathological grades of bladder TCC. Specifically, both TβR-I and TβR-II were readily detected in all 10 normal bladder mucosa specimens. Likewise, all 6 specimens of grade I TCC samples expressed high levels of both TGF-β receptors. However, among grade II TCC samples, TβR-I and TβR-II were detected in 78% and 89%, respectively: among grade III TCC samples, TβR-I and TβR-II were detected in 45% and 41%, respectively. These results suggested that loss of sensitivity to TGF-β may play a role in the progression of TCC from low to high grade disease.

Original languageEnglish
Pages (from-to)118-123
Number of pages6
JournalYonsei medical journal
Volume40
Issue number2
DOIs
Publication statusPublished - 1999 Apr

Fingerprint

Growth Factor Receptors
Transitional Cell Carcinoma
Transforming Growth Factors
Urinary Bladder
Neoplasms
Intercellular Signaling Peptides and Proteins
Carcinogenesis
Mucous Membrane
Epithelial Cells
Immunohistochemistry
Cell Proliferation

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Lee, Dong Hyeon ; Yang, Seung Choul ; Hong, Sung Joon ; Chung, Byung Ha ; Chung, Hyun Jik ; Tokunaga, Hideo ; Kim, Isaac Y. ; Song, Yun S. ; Lerner, Seth P. ; Morton, Ronald A. / The Loss of Expression of Transforming Growth Factor-β Receptors Correlates with the Histopathologic Tumor Grade in Bladder Transitional Cell Carcinoma Patients. In: Yonsei medical journal. 1999 ; Vol. 40, No. 2. pp. 118-123.
@article{5beee37e19884e1dbbb1da2dd385a5eb,
title = "The Loss of Expression of Transforming Growth Factor-β Receptors Correlates with the Histopathologic Tumor Grade in Bladder Transitional Cell Carcinoma Patients",
abstract = "Transforming growth factor-β (TGF-β), a pleiotropic growth factor, is a potent inhibitor of cellular proliferation in cells of epithelial origin. Recently, it has been suggested that a loss of sensitivity to TGF- β through a loss of expression of TGF-β receptors TβSR-I and TβR-II - is associated with tumor initiation and progression. Therefore, to investigate the relationship between TGF-β receptors expression and carcinogenesis of bladder TCC, this study examined the expression of TβR-I and TβR-II in 46 bladder TCC patients using immunohistochemistry. Since histopathological grade is a widely accepted marker of prognosis, the results were compared in relation to the three grades of bladder TCC. The results demonstrated that the loss of TGF-β receptors expression is associated with increasing histopathological grades of bladder TCC. Specifically, both TβR-I and TβR-II were readily detected in all 10 normal bladder mucosa specimens. Likewise, all 6 specimens of grade I TCC samples expressed high levels of both TGF-β receptors. However, among grade II TCC samples, TβR-I and TβR-II were detected in 78{\%} and 89{\%}, respectively: among grade III TCC samples, TβR-I and TβR-II were detected in 45{\%} and 41{\%}, respectively. These results suggested that loss of sensitivity to TGF-β may play a role in the progression of TCC from low to high grade disease.",
author = "Lee, {Dong Hyeon} and Yang, {Seung Choul} and Hong, {Sung Joon} and Chung, {Byung Ha} and Chung, {Hyun Jik} and Hideo Tokunaga and Kim, {Isaac Y.} and Song, {Yun S.} and Lerner, {Seth P.} and Morton, {Ronald A.}",
year = "1999",
month = "4",
doi = "10.3349/ymj.1999.40.2.118",
language = "English",
volume = "40",
pages = "118--123",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "2",

}

The Loss of Expression of Transforming Growth Factor-β Receptors Correlates with the Histopathologic Tumor Grade in Bladder Transitional Cell Carcinoma Patients. / Lee, Dong Hyeon; Yang, Seung Choul; Hong, Sung Joon; Chung, Byung Ha; Chung, Hyun Jik; Tokunaga, Hideo; Kim, Isaac Y.; Song, Yun S.; Lerner, Seth P.; Morton, Ronald A.

In: Yonsei medical journal, Vol. 40, No. 2, 04.1999, p. 118-123.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The Loss of Expression of Transforming Growth Factor-β Receptors Correlates with the Histopathologic Tumor Grade in Bladder Transitional Cell Carcinoma Patients

AU - Lee, Dong Hyeon

AU - Yang, Seung Choul

AU - Hong, Sung Joon

AU - Chung, Byung Ha

AU - Chung, Hyun Jik

AU - Tokunaga, Hideo

AU - Kim, Isaac Y.

AU - Song, Yun S.

AU - Lerner, Seth P.

AU - Morton, Ronald A.

PY - 1999/4

Y1 - 1999/4

N2 - Transforming growth factor-β (TGF-β), a pleiotropic growth factor, is a potent inhibitor of cellular proliferation in cells of epithelial origin. Recently, it has been suggested that a loss of sensitivity to TGF- β through a loss of expression of TGF-β receptors TβSR-I and TβR-II - is associated with tumor initiation and progression. Therefore, to investigate the relationship between TGF-β receptors expression and carcinogenesis of bladder TCC, this study examined the expression of TβR-I and TβR-II in 46 bladder TCC patients using immunohistochemistry. Since histopathological grade is a widely accepted marker of prognosis, the results were compared in relation to the three grades of bladder TCC. The results demonstrated that the loss of TGF-β receptors expression is associated with increasing histopathological grades of bladder TCC. Specifically, both TβR-I and TβR-II were readily detected in all 10 normal bladder mucosa specimens. Likewise, all 6 specimens of grade I TCC samples expressed high levels of both TGF-β receptors. However, among grade II TCC samples, TβR-I and TβR-II were detected in 78% and 89%, respectively: among grade III TCC samples, TβR-I and TβR-II were detected in 45% and 41%, respectively. These results suggested that loss of sensitivity to TGF-β may play a role in the progression of TCC from low to high grade disease.

AB - Transforming growth factor-β (TGF-β), a pleiotropic growth factor, is a potent inhibitor of cellular proliferation in cells of epithelial origin. Recently, it has been suggested that a loss of sensitivity to TGF- β through a loss of expression of TGF-β receptors TβSR-I and TβR-II - is associated with tumor initiation and progression. Therefore, to investigate the relationship between TGF-β receptors expression and carcinogenesis of bladder TCC, this study examined the expression of TβR-I and TβR-II in 46 bladder TCC patients using immunohistochemistry. Since histopathological grade is a widely accepted marker of prognosis, the results were compared in relation to the three grades of bladder TCC. The results demonstrated that the loss of TGF-β receptors expression is associated with increasing histopathological grades of bladder TCC. Specifically, both TβR-I and TβR-II were readily detected in all 10 normal bladder mucosa specimens. Likewise, all 6 specimens of grade I TCC samples expressed high levels of both TGF-β receptors. However, among grade II TCC samples, TβR-I and TβR-II were detected in 78% and 89%, respectively: among grade III TCC samples, TβR-I and TβR-II were detected in 45% and 41%, respectively. These results suggested that loss of sensitivity to TGF-β may play a role in the progression of TCC from low to high grade disease.

UR - http://www.scopus.com/inward/record.url?scp=0033112242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033112242&partnerID=8YFLogxK

U2 - 10.3349/ymj.1999.40.2.118

DO - 10.3349/ymj.1999.40.2.118

M3 - Article

C2 - 10333714

AN - SCOPUS:0033112242

VL - 40

SP - 118

EP - 123

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 2

ER -